Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Deficit Accumulated
Beginning balance (in shares) at Dec. 31, 2021		6,910,324
Beginning balance at Dec. 31, 2021	$ 36,117	$ 7	$ 136,173	$ (100,063)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercised of stock options (in shares)	0
Issuance of common stock for cash, net of issuance cost (in shares)		3,608,215
Issuance of common stock for cash, net of issuance cost	$ 8,861	$ 4	8,857
Share-based compensation	1,561		1,561
Issuance of common stock warrants	7,281		7,281
Net loss	(35,709)			(35,709)
Ending balance (in shares) at Dec. 31, 2022		10,518,539
Ending balance at Dec. 31, 2022	$ 18,111	$ 11	153,872	(135,772)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercised of stock options (in shares)	713	713
Exercised of stock options	$ 1		1
Issuance of common stock for cash, net of issuance cost (in shares)		8,323,218
Issuance of common stock for cash, net of issuance cost	35,598	$ 8	35,590
Exercise of pre-funded warrants(in shares)		3,202,785
Exercise of pre-funded warrants	3	$ 3
Share-based compensation	2,546		2,546
Net loss	(29,491)			(29,491)
Ending balance (in shares) at Dec. 31, 2023		22,045,255
Ending balance at Dec. 31, 2023	$ 26,768	$ 22	$ 192,009	$ (165,263)